Polyphor Ltd., a clinical stage, privately held Swiss specialty pharma company focused on the development of macrocycle drugs addressing antibiotic resistance and respiratory diseases, has completed a CHF 40 m private placement. Exisiting Polyphor investors, including the anchor investors Varuma AG and Ingro Finanz AG, contributed to 98% of the financing. VISCHER assisted Polpyhor in this transaction. The team at VISCHER was lead by Matthias Staehelin with Luzius Zumstein (both Corporate).

On Monday 10 April, trading started in FM Mattsson Mora Group’s shares at Nasdaq Stockholm. The Offering attracted a great deal of interest, from both institutional investors and the Swedish public and was substantially oversubscribed.

FM Mattsson Mora Group develops and manufactures water taps and accessories. The company primarily operates in the Nordic region and its products are sold under the brands FM Mattsson, Mora Armatur and Damixa. FM Mattsson Mora Group was originally established in 1865, currently employs 550 professionals and is headquartered in Mora, Sweden.

    Raymond Tong, Johannes Juette, Jonathan Crandall, Stephanie Juwita Liman

    Clifford Chance, Singapore

Clifford Chance advised the issuer, Eco World International Berhad (EWI), on the international aspects of its US$580million (RM2.58 billion) initial public offering (IPO) on the Main Market of Bursa Malaysia Securities Bhd. This is the largest IPO in Malaysia since the listing of Malakoff Corporation Berhad in 2015, on which Clifford Chance also advised on.

Travers Smith LLP has acted for Liberum Capital Limited in its capacity as financial adviser and bookrunner on the launch of EJF Investments Limited (the Fund) on the London Stock Exchange's Specialist Fund Segment today.

The Fund intends to invest in a diversified portfolio of investments created by regulatory and structural changes impacting on the financial services sector.

Baker McKenzie is acting for FAR Limited on the fully underwritten placement to institutional and sophisticated investors to raise AUD$80 million.

Baker McKenzie's lead partner on the transaction, Richard Lustig stated:

    We are delighted to act for our client, FAR Limited on what is a significant capital raising with strong support by both new and existing investors.

Heuking Kühn Lüer Wojtek advised DATAGROUP SE on a capital increase against cash contributions with exclusion of subscription rights. The company has generated proceeds of some EUR 21.7 million from the transaction.
 
759,000 new shares were placed with institutional investors as part of the capital increase. The company intends to strengthen its equity and finance further growth with the gross issue proceeds of EUR 21.7 million. The new shares are to be admitted to OTC trading on the Frankfurt Stock Exchange with simultaneous inclusion in the "Scale" segment.

Vinge has advised Actic Group AB (publ) (“Actic”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 28 March 2017 and the first day of trading on Nasdaq Stockholm was 7 April 2017. The price in the offering was SEK 50.50 per share, corresponding to a market value of Actic of approximately SEK 800 million. The offering comprised 8,613,860 shares, of which 5,346,534 shares were newly issued shares and 3,267,326 were existing shares offered by the selling shareholder Actic International S.à r.l., which is owned by the IK 2007 Fund.

Herbert Smith Freehills has advised Hong Kong-based China Huarong International Holdings Ltd (Huarong) on its US$18 million investment via convertible notes into Bionic Vision Technologies Pty Ltd (BVT), an Australian company owned by a series of university research vehicles.

BVT has been established to develop and commercialise bionic eye implants to help restore limited vision to people with retinitis pigmentosa.

Rejlers has carried out a rights issue with preferential rights for the shareholders, for which the subscription period ended on March 31, 2017. Through the rights issue, which was oversubscribed by 35 per cent, Rejlers will receive proceeds amounting to approximately SEK 200 million before issue costs.

Travers Smith LLP has acted for Numis Securities Limited in its capacity as placing agent and sole bookrunner on the US$69 million placing and offer for subscription of C shares by Fair Oaks Income Limited ("FOIL"), an investor in US and European CLOs, and other vehicles which provide exposure to high-yielding floating rate senior secured loans. 

The C shares were admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange on 5 April 2017.